Vascular endothelial growth factor induces expression of connective tissue growth factor via KDR, Flt1, and phosphatidylinositol 3-kinase-akt-dependent pathways in retinal vascular cells - PubMed (original) (raw)
. 2000 Dec 29;275(52):40725-31.
doi: 10.1074/jbc.M006509200.
Affiliations
- PMID: 11018037
- DOI: 10.1074/jbc.M006509200
Free article
Vascular endothelial growth factor induces expression of connective tissue growth factor via KDR, Flt1, and phosphatidylinositol 3-kinase-akt-dependent pathways in retinal vascular cells
K Suzuma et al. J Biol Chem. 2000.
Free article
Abstract
Fibroblastic proliferation accompanies many angiogenesis-related retinal and systemic diseases. Since connective tissue growth factor (CTGF) is a potent mitogen for fibrosis, extracellular matrix production, and angiogenesis, we have studied the effects and mechanism by which vascular endothelial growth factor (VEGF) regulates CTGF gene expression in retinal capillary cells. In our study, VEGF increased CTGF mRNA levels in a time- and concentration-dependent manner in bovine retinal endothelial cells and pericytes, without the need of new protein synthesis and without altering mRNA stability. VEGF activated the tyrosine receptor phosphorylation of KDR and Flt1 and increased the binding of phosphatidylinositol 3-kinase (PI3-kinase) p85 subunit to KDR and Flt1, both of which could mediate CTGF gene induction. VEGF-induced CTGF expression was mediated primarily by PI3-kinase activation, whereas PKC and ERK pathways made only minimal contributions. Furthermore, overexpression of constitutive active Akt was sufficient to induce CTGF gene expression, and inhibition of Akt activation by overexpressing dominant negative mutant of Akt abolished the VEGF-induced CTGF expression. These data suggest that VEGF can increase CTGF gene expression in bovine retinal capillary cells via KDR or Flt receptors and the activation of PI3-kinase-Akt pathway independently of PKC or Ras-ERK pathway, possibly inducing the fibrosis observed in retinal neovascular diseases.
Similar articles
- Stretch-induced retinal vascular endothelial growth factor expression is mediated by phosphatidylinositol 3-kinase and protein kinase C (PKC)-zeta but not by stretch-induced ERK1/2, Akt, Ras, or classical/novel PKC pathways.
Suzuma I, Suzuma K, Ueki K, Hata Y, Feener EP, King GL, Aiello LP. Suzuma I, et al. J Biol Chem. 2002 Jan 11;277(2):1047-57. doi: 10.1074/jbc.M105336200. Epub 2001 Nov 1. J Biol Chem. 2002. PMID: 11694503 - VEGF activates protein kinase C-dependent, but Ras-independent Raf-MEK-MAP kinase pathway for DNA synthesis in primary endothelial cells.
Takahashi T, Ueno H, Shibuya M. Takahashi T, et al. Oncogene. 1999 Apr 1;18(13):2221-30. doi: 10.1038/sj.onc.1202527. Oncogene. 1999. PMID: 10327068 - Vascular endothelial growth factor regulates endothelial cell survival through the phosphatidylinositol 3'-kinase/Akt signal transduction pathway. Requirement for Flk-1/KDR activation.
Gerber HP, McMurtrey A, Kowalski J, Yan M, Keyt BA, Dixit V, Ferrara N. Gerber HP, et al. J Biol Chem. 1998 Nov 13;273(46):30336-43. doi: 10.1074/jbc.273.46.30336. J Biol Chem. 1998. PMID: 9804796 - Properties of two VEGF receptors, Flt-1 and KDR, in signal transduction.
Sato Y, Kanno S, Oda N, Abe M, Ito M, Shitara K, Shibuya M. Sato Y, et al. Ann N Y Acad Sci. 2000 May;902:201-5; discussion 205-7. doi: 10.1111/j.1749-6632.2000.tb06314.x. Ann N Y Acad Sci. 2000. PMID: 10865839 Review. - Possible involvement of VEGF-FLT tyrosine kinase receptor system in normal and tumor angiogenesis.
Shibuya M, Seetharam L, Ishii Y, Sawano A, Gotoh N, Matsushime H, Yamaguchi S. Shibuya M, et al. Princess Takamatsu Symp. 1994;24:162-70. Princess Takamatsu Symp. 1994. PMID: 8983073 Review.
Cited by
- Central Adiponectin Signaling - A Metabolic Regulator in Support of Brain Plasticity.
Formolo DA, Cheng T, Yu J, Kranz GS, Yau SY. Formolo DA, et al. Brain Plast. 2022 Oct 21;8(1):79-96. doi: 10.3233/BPL-220138. eCollection 2022. Brain Plast. 2022. PMID: 36448043 Free PMC article. Review. - The role of the ERK signaling pathway in promoting angiogenesis for treating ischemic diseases.
Song YY, Liang D, Liu DK, Lin L, Zhang L, Yang WQ. Song YY, et al. Front Cell Dev Biol. 2023 Jun 22;11:1164166. doi: 10.3389/fcell.2023.1164166. eCollection 2023. Front Cell Dev Biol. 2023. PMID: 37427386 Free PMC article. Review. - Connective Tissue Growth Factor Domain 4 Amplifies Fibrotic Kidney Disease through Activation of LDL Receptor-Related Protein 6.
Johnson BG, Ren S, Karaca G, Gomez IG, Fligny C, Smith B, Ergun A, Locke G, Gao B, Hayes S, MacDonnell S, Duffield JS. Johnson BG, et al. J Am Soc Nephrol. 2017 Jun;28(6):1769-1782. doi: 10.1681/ASN.2016080826. Epub 2017 Jan 27. J Am Soc Nephrol. 2017. PMID: 28130402 Free PMC article. - Simultaneous application of bevacizumab and anti-CTGF antibody effectively suppresses proangiogenic and profibrotic factors in human RPE cells.
Bagheri A, Soheili ZS, Ahmadieh H, Samiei S, Sheibani N, Astaneh SD, Kanavi MR, Mohammadian A. Bagheri A, et al. Mol Vis. 2015 Apr 10;21:378-90. eCollection 2015. Mol Vis. 2015. PMID: 25883524 Free PMC article. - Gold nanoparticles enhance cisplatin delivery and potentiate chemotherapy by decompressing colorectal cancer vessels.
Zhao X, Pan J, Li W, Yang W, Qin L, Pan Y. Zhao X, et al. Int J Nanomedicine. 2018 Oct 9;13:6207-6221. doi: 10.2147/IJN.S176928. eCollection 2018. Int J Nanomedicine. 2018. PMID: 30349245 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Miscellaneous